Clinical Trials Directory

Trials / Completed

CompletedNCT00870805

Ultrabrief Pulsewidth Electroconvulsive Therapy (ECT)

A Controlled Study of Ultrabrief Pulsewidth ECT (Electroconvulsive Therapy)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
150 (actual)
Sponsor
The University of New South Wales · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Electroconvulsive Therapy (ECT) remains essential to contemporary psychiatric practice and is one of the safest and most effective treatments available for depression. Despite modern advances in pharmacotherapy, about 15-20 per cent of all hospitalised patients receive treatment with ECT. Its use, however, is limited by concerns over associated cognitive side effects. Recent research has suggested that using an ultrabrief pulsewidth with ECT may greatly reduce cognitive side effects, while maintaining efficacy (Sackeim et al 2008). Preliminary results were positive for unilateral ECT, however, suggest that for bilateral ECT, dosing may need to be adjusted to preserve efficacy while reducing side effects. This study will examine the relative cognitive side effects and efficacy of right unilateral and bilateral ECT given with a standard pulsewidth or an ultrabrief pulsewidth. Some participants will also receive an MRI scan before and after ECT.

Conditions

Interventions

TypeNameDescription
PROCEDUREbilateral ultrabrief ECTBilateral ECT at 3-4 times seizure threshold with an ultrabrief pulse (0.3ms)
PROCEDUREbilateral standard ECTBilateral ECT with at 1.5 times seizure threshold with a standard pulse (1.0ms)
PROCEDUREright-unilateral ultrabrief ECTRight-unilateral ECT at 6 times seizure threshold with an ultrabrief pulse (0.3ms)
PROCEDUREright-unilateral standard ECTRight-unilateral ECT with at 5 times seizure threshold with a standard pulse (1.0ms)

Timeline

Start date
2009-01-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2009-03-27
Last updated
2013-02-27

Locations

3 sites across 1 country: Australia

Source: ClinicalTrials.gov record NCT00870805. Inclusion in this directory is not an endorsement.